๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

342 POSTER A phase I dose-escalation and pharmacokinetic (PK) study of XL647, a novel spectrum selective kinase inhibitor, administered orally to patients with advanced solid malignancies (ASM)

โœ Scribed by B.I. Sikic; H.A. Wakelee; A.A. Adjei; J. Halsey; J.L. Lensing; J.D. Dugay; L.J. Hanson; J.M. Reid; J.R. Piens


Book ID
118623970
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
68 KB
Volume
4
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES